ACR Basic & Clinical Research Conference: Disrupting the Genetics of Rheumatology: The Role of Somatic Mutations in Health and Disease

ACR基础

• 批准号: 10540583
• 负责人: Kristine A. Kuhn
• 金额: $ 6万
• 依托单位: AMERICAN COLLEGE OF RHEUMATOLOGY
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-09-01 至 2027-08-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10540583
• 关键词: Advocacy; Affect; American; Arthritis; Basic Science; Biology; Characteristics; Clinical; Clinical Research; Clinical Services; Colorado; Communities; Degenerative polyarthritis; Department chair; Development; Discipline; Disease; Education; Epidemiology; Event; Evolution; Fostering; Genetic; Genome; Goals; Grant; Head; Health; Health Services Research; Healthcare; Human; Immunology; Immunotherapeutic agent; Investigation; Israel; Knowledge; Laboratories; Medical; Medical Research; Medical center; Medicine; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Oral; Pain; Participant; Patient Care; Patients; Persons; Physiology; Practice Management; Public Health; Public Health Schools; Research; Research Institute; Research Personnel; Research Training; Resources; Rheumatism; Rheumatology; Role; Schedule; Scientist; Somatic Mutation; Spondylarthritis; Time; Training; Translating; Translational Research; Underrepresented Minority; United States National Institutes of Health; Universities; chronic pain; clinical practice; college; coronavirus disease; cost; genetic epidemiology; improved; insight; interest; meetings; mid-career faculty; novel therapeutics; professor; programs; symposium; virtual

Project Summary-Abstract The American College of Rheumatology (ACR) has been a leader in the effort to facilitate the bidirectional exchange of cutting-edge scientific information between scientists and investigators in rheumatic diseases through its annual Basic and Clinical Research Conferences. The ACR has successfully hosted the conference as separate programs and as a combined basic science and clinical research program, as well as both in- person and virtually. Each program has been held in conjunction with ACR’s annual meeting, Convergence. The ACR annual meeting, ACR Convergence, attracts between 10,000 and 15,000 attendees each year and is the principal mechanism for providing a forum for the exchange of ideas about research, education, patient care, practice management and advocacy issues. Because the Basic and Clinical Research Conferences have been held in conjunction with ACR Convergence, typically as a pre-meeting event, ACR has been able to attract renown scientists and investigators who may otherwise not have attended. For 2022, the Basic and Clinical Research Conference will be held jointly to attract scientists and investigators from both the basic, clinical and translational research communities. The tentative title of the conference is Disrupting the Genetics of Rheumatology: The Role of Somatic Mutations in Health and Disease . This combined approach will focus on the role of somatic mutations in the development rheumatologic diseases. Clinical research sessions will focus on genetic epidemiology approaches for associating somatic mutations with disease. Basic research sessions will explore topics such as identification of the presence and functional role of somatic mutations. The conference organizers include Dr. Jill Norris, Professor and Chair of the Department of Epidemiology at the Colorado School of Public Health; Dr. Peter Grayson, Earl Stadtman Investigator at the NIAMS; Dr. Linda Hiraki, ACR Committee on Research Liaison, Clinician-Scientist in the Division of Rheumatology and Scientist in Genetics & Genome Biology at SickKids Research Institute; Dr. Iannis Adampopoulos, ACR Committee on Research Liaison, Director of the Arthritis Program and Head of Osteoimmunity Laboratory at the Beth Israel Deaconess Medical Center; and Dr. Kristine Kuhn, ACR Committee on Research Chair and Associate Professor of Medicine-Rheumatology at the University of Colorado and the Co-Director of the University of Colorado Program for Advancing Spondyloarthritis Treatment. The ACR Committee on Research focuses on research and research training in rheumatology and encourages clinical and health services research on the organization of medical and health care as they may affect patients with rheumatic diseases.

项目概要-摘要 美国风湿病学会 (ACR) 一直是促进双向治疗的领导者 风湿病科学家和研究人员之间交流尖端科学信息 通过其年度基础和临床研究会议。 ACR成功主办了本次会议 作为单独的项目和作为基础科学和临床研究相结合的项目，以及两者 人和虚拟人。每个项目均与 ACR 年会 Convergence 一起举行。 ACR 年会 ACR Convergence 每年吸引 10,000 至 15,000 名与会者， 为研究、教育、患者交流思想提供论坛的主要机制 护理、实践管理和宣传问题。因为基础和临床研究会议有 与 ACR Convergence 一起举行，通常作为会前活动，ACR 能够 吸引原本可能不会参加的著名科学家和研究人员。 2022年将联合举办基础与临床研究会议，吸引科学家和研究者 来自基础、临床和转化研究界。会议暂定名称为 破坏风湿病遗传学：体细胞突变在健康和疾病中的作用。这 联合方法将重点关注体细胞突变在风湿病发展中的作用。 临床研究会议将重点关注关联体细胞突变的遗传流行病学方法 患有疾病。基础研究课程将探讨诸如存在和功能识别等主题 体细胞突变的作用。 会议组织者包括吉尔·诺里斯 (Jill Norris) 博士，他是该大学流行病学系教授兼系主任。 科罗拉多公共卫生学院； Peter Grayson 博士，NIAMS 的 Earl Stadtman 研究员；琳达博士 Hiraki，ACR 研究联络委员会、风湿病科临床医生兼科学家 SickKids 研究所遗传学和基因组生物学博士； Iannis Adampopoulos 博士，ACR 委员会 研究联络员、贝斯以色列关节炎项目主任兼骨免疫实验室主任 女执事医疗中心；克里斯汀·库恩 (Kristine Kuhn) 博士，ACR 研究委员会主席兼助理 科罗拉多大学医学风湿病学教授兼科罗拉多大学联合主任 科罗拉多州推进脊柱关节炎治疗计划。 ACR 研究委员会重点关注 风湿病学方面的研究和研究培训，并鼓励有关风湿病学的临床和卫生服务研究 组织医疗和保健，因为它们可能影响风湿病患者。